Oncorus, Inc.
ONCR · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $54,744 | $44,682 | $27,153 | $24,047 |
| G&A Expenses | $21,793 | $20,136 | $10,000 | $7,119 |
| SG&A Expenses | $21,793 | $20,136 | $10,000 | $7,119 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$9 | $0 | -$47 |
| Operating Expenses | $76,537 | $64,818 | $37,153 | $31,166 |
| Operating Income | -$76,537 | -$64,818 | -$37,153 | -$31,166 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$885 | $56 | -$11,146 | $462 |
| Pre-Tax Income | -$77,422 | -$64,762 | -$48,299 | -$30,704 |
| Tax Expense | $885 | -$65 | -$1,516 | -$509 |
| Net Income | -$78,307 | -$64,697 | -$46,783 | -$30,195 |
| % Margin | – | – | – | – |
| EPS | -3.02 | -2.56 | -7.69 | -2.42 |
| % Growth | -18% | 66.7% | -217.8% | – |
| EPS Diluted | -3.02 | -2.56 | -7.69 | -2.42 |
| Weighted Avg Shares Out | 25,924 | 25,320 | 6,080 | 12,502 |
| Weighted Avg Shares Out Dil | 25,924 | 25,320 | 6,080 | 12,502 |
| Supplemental Information | – | – | – | – |
| Interest Income | $911 | $65 | $143 | $509 |
| Interest Expense | $2,006 | $0 | $0 | $0 |
| Depreciation & Amortization | $3,632 | $1,948 | $1,373 | $1,071 |
| EBITDA | -$71,784 | -$62,870 | -$37,153 | -$30,095 |
| % Margin | – | – | – | – |